RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kissei Pharmaceutical Co Stock

Kissei Pharmaceutical Co ROCE 2024

Kissei Pharmaceutical Co ROCE

0.02

Ticker

4547.T

ISIN

JP3240600001

WKN

881370

In 2024, Kissei Pharmaceutical Co's return on capital employed (ROCE) was 0.02, a -362.24% increase from the -0.01 ROCE in the previous year.

Kissei Pharmaceutical Co Aktienanalyse

What does Kissei Pharmaceutical Co do?

Kissei Pharmaceutical Co., Ltd. is a leading innovative company in Japan that focuses on the development and production of pharmaceuticals for various diseases. The Kissei Group consists of several companies that work together in the development and production of pharmaceuticals and other medical products. History: Kissei Pharmaceutical was founded in 1946 in Matsumoto, Japan. The company initially manufactured drugs for skin and respiratory diseases and later expanded its portfolio to include drugs for cancer and Parkinson's. Over time, Kissei Pharmaceutical has also invested in research and development and has become a key player in the global pharmaceutical industry. Business model: Kissei Pharmaceutical's business model is based on the development and marketing of innovative drugs for various diseases. The company's strategy is to focus on niche markets and invest in research and development to develop groundbreaking drugs. The company also seeks partnerships and has a strong presence in the Asian market. Divisions: Kissei Pharmaceutical is divided into various business areas, including cancer, neurological disorders, metabolic disorders, and dermatological diseases. The largest business area is oncology, where the company offers many products for the treatment of cancer. The neurology division includes products for the treatment of Parkinson's and Alzheimer's. In the field of metabolic disorders, Kissei Pharmaceutical offers drugs for the treatment of diabetes and obesity. In dermatology, the products include skincare products for various skin conditions such as eczema and psoriasis. Products: Kissei Pharmaceutical offers a wide range of pharmaceutical products for a variety of diseases. In the field of oncology, the company produces drugs such as docetaxel for breast and lung cancer, and irinotecan for colon cancer. In the field of neurological disorders, Kissei Pharmaceutical produces drugs such as levodopa for Parkinson's, and TAK-659 for cancer patients with high blood sugar levels. In the field of metabolic disorders, the company produces drugs such as insulin for the treatment of diabetes, and leptin for the treatment of obesity. In dermatology, Kissei Pharmaceutical produces drugs such as epicederm for eczema and psoriasis, and apimo for acne. Conclusion: Kissei Pharmaceutical is an innovative company in Japan that specializes in the development and production of pharmaceuticals for various diseases. The company has a strong presence in the Asian market and works closely with partners to develop new drugs. With its various business divisions and wide range of products, Kissei Pharmaceutical is a key player in the global pharmaceutical industry. Kissei Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Kissei Pharmaceutical Co's Return on Capital Employed (ROCE)

Kissei Pharmaceutical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Kissei Pharmaceutical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Kissei Pharmaceutical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Kissei Pharmaceutical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Kissei Pharmaceutical Co stock

What is the ROCE (Return on Capital Employed) of Kissei Pharmaceutical Co this year?

The ROCE of Kissei Pharmaceutical Co is 0.02 undefined this year.

How has the ROCE (Return on Capital Employed) of Kissei Pharmaceutical Co developed compared to the previous year?

The ROCE of Kissei Pharmaceutical Co has increased by -362.24% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Kissei Pharmaceutical Co?

A high Return on Capital Employed (ROCE) indicates that Kissei Pharmaceutical Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Kissei Pharmaceutical Co?

A low ROCE (Return on Capital Employed) can indicate that Kissei Pharmaceutical Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Kissei Pharmaceutical Co impact the company?

An increase in the ROCE of Kissei Pharmaceutical Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Kissei Pharmaceutical Co affect the company?

A decrease in ROCE of Kissei Pharmaceutical Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Kissei Pharmaceutical Co?

Some factors that can affect Kissei Pharmaceutical Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Kissei Pharmaceutical Co so important for investors?

The ROCE of Kissei Pharmaceutical Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Kissei Pharmaceutical Co take to improve the ROCE?

To improve the ROCE, Kissei Pharmaceutical Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Kissei Pharmaceutical Co pay?

Over the past 12 months, Kissei Pharmaceutical Co paid a dividend of 86 JPY . This corresponds to a dividend yield of about 2.31 %. For the coming 12 months, Kissei Pharmaceutical Co is expected to pay a dividend of 89.31 JPY.

What is the dividend yield of Kissei Pharmaceutical Co?

The current dividend yield of Kissei Pharmaceutical Co is 2.31 %.

When does Kissei Pharmaceutical Co pay dividends?

Kissei Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Kissei Pharmaceutical Co?

Kissei Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Kissei Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 89.31 JPY are expected. This corresponds to a dividend yield of 2.4 %.

In which sector is Kissei Pharmaceutical Co located?

Kissei Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kissei Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kissei Pharmaceutical Co from 12/1/2024 amounting to 45 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Kissei Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Kissei Pharmaceutical Co in the year 2023?

In the year 2023, Kissei Pharmaceutical Co distributed 81 JPY as dividends.

In which currency does Kissei Pharmaceutical Co pay out the dividend?

The dividends of Kissei Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kissei Pharmaceutical Co

Our stock analysis for Kissei Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kissei Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.